Skip to main content
logo
Galderma Group AG (GALDY)
OTCMKTS · Delayed Price · Currency is USD
40.69
-0.85 (-2.05%)
At close: Jan 8, 2026

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Neuromodulators Revenue
1.37B1.29B
Log In
Log In
Log In
Fillers & Biostimulators Revenue
1.03B1.01B
Log In
Log In
Log In
Injectable Aesthetics Revenue
2.40B2.30B
Log In
Log In
Log In
Dermatological Skincare Revenue
1.38B1.33B
Log In
Log In
Log In
Therapeutic Dermatology Revenue
881.00M780.00M
Log In
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
USA Revenue
1.92B1.81B
Log In
Log In
Log In
International Revenue
2.73B2.60B
Log In
Log In
Log In

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Neuromodulators Constant Currency Growth
11.80%
Log In
Log In
Log In
Fillers & Biostimulators Constant Currency Growth
7.00%
Log In
Log In
Log In
Injectable Aesthetics Constant Currency Growth
9.60%
Log In
Log In
Log In
Dermatological Skincare Constant Currency Growth
10.70%
Log In
Log In
Log In
Therapeutic Dermatology Constant Currency Growth
6.10%
Log In
Log In
Log In
Total Constant Currency Growth
9.30%
Log In
Log In
Log In
Updated Jun 30, 2025. Data Source: Fiscal.ai.